139 related articles for article (PubMed ID: 15746637)
1. Recombinant factor VIIa use in cardiac surgery--expanding the arsenal therapy for intractable bleeding?
Kogan A; Berman M; Stein M; Vidne BA; Raanani E
J Cardiovasc Surg (Torino); 2004 Dec; 45(6):569-71. PubMed ID: 15746637
[TBL] [Abstract][Full Text] [Related]
2. Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding.
Vanek T; Straka Z; Hrabak J; Jares M; Brucek PJ; Votava J
Jpn Heart J; 2004 Sep; 45(5):855-60. PubMed ID: 15557726
[TBL] [Abstract][Full Text] [Related]
3. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
[TBL] [Abstract][Full Text] [Related]
4. Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients.
Tobias JD; Simsic JM; Weinstein S; Schechter W; Kartha V; Michler R
J Intensive Care Med; 2004; 19(5):270-3. PubMed ID: 15358945
[TBL] [Abstract][Full Text] [Related]
5. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
Raivio P; Suojaranta-Ylinen R; Kuitunen AH
Ann Thorac Surg; 2005 Jul; 80(1):66-71. PubMed ID: 15975342
[TBL] [Abstract][Full Text] [Related]
6. Successful graft patency after factor VIIa use for bleeding in coronary artery surgery: an unusual complication of a coronary artery bypass surgery.
Wahed S; Karagounis AP; Niranjan G; Kanagasabay R
J Card Surg; 2007; 22(5):424-7. PubMed ID: 17803583
[TBL] [Abstract][Full Text] [Related]
7. Recombinant activated factor VII for life-threatening pulmonary hemorrhage after pediatric cardiac surgery.
Leibovitch L; Kenet G; Mazor K; Matok I; Vardi A; Barzilay Z; Paret G
Pediatr Crit Care Med; 2003 Oct; 4(4):444-6. PubMed ID: 14525639
[TBL] [Abstract][Full Text] [Related]
8. Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin.
Oh JJ; Akers WS; Lewis D; Ramaiah C; Flynn JD
Pharmacotherapy; 2006 Apr; 26(4):569-577. PubMed ID: 16553518
[TBL] [Abstract][Full Text] [Related]
9. Intra-Pericardial Use of Recombinant Factor VIIa in a Patient With Acute Hemorrhagic Pericardial Effusion Following Transcutaneous Aortic Valve Replacement-A Case Report.
Jaitly V; Klein K; Tint H; Chen A; Allison P; Akkanti B; Loyalka P; Castillo B
Lab Med; 2017 Aug; 48(3):262-265. PubMed ID: 28934519
[TBL] [Abstract][Full Text] [Related]
10. Fatal rupture of splenic artery mycotic aneurysm after mitral valve replacement for infective endocarditis.
Charokopos NA; Foroulis CN; Rouska EG; Papakonstantinou C
Eur J Cardiothorac Surg; 2009 Oct; 36(4):783-4; author reply 784-5. PubMed ID: 19695899
[No Abstract] [Full Text] [Related]
11. Off-label use of recombinant factor VIIA concentrates after cardiac surgery.
Despotis G; Avidan M; Lublin DM
Ann Thorac Surg; 2005 Jul; 80(1):3-5. PubMed ID: 15975330
[No Abstract] [Full Text] [Related]
12. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
Cağlar K; Cetinkaya A; Aytaç S; Gümrük F; Gürgey A
Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of recombinant activated factor VII for treatment of life-threatening bleeding in cardiac surgery].
Hamdani M; Bouzguenda H; Jebali MA; Ferjani M; Ziadi M; Chenik S
Ann Fr Anesth Reanim; 2007; 26(7-8):712-4. PubMed ID: 17574372
[No Abstract] [Full Text] [Related]
14. Use of recombinant activated factor VII after axillofemoral bypass grafting.
Cheng CA; Ho AM
Anaesth Intensive Care; 2006 Jun; 34(3):375-8. PubMed ID: 16802495
[TBL] [Abstract][Full Text] [Related]
15. Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery.
McCall P; Story DA; Karalapillai D
Can J Anaesth; 2006 Sep; 53(9):926-33. PubMed ID: 16960271
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic therapy for postoperative bleeding in children after cardiac surgery: when will the bleeding stop?
Yan Q; Chang AC
Pediatr Crit Care Med; 2004 May; 5(3):297-8. PubMed ID: 15167716
[No Abstract] [Full Text] [Related]
17. Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven).
Tanaka KA; Waly AA; Cooper WA; Levy JH
Anesthesiology; 2003 Jun; 98(6):1513-5. PubMed ID: 12766668
[No Abstract] [Full Text] [Related]
18. The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.
Tofil NM; Winkler MK; Watts RG; Noonan J
Pediatr Crit Care Med; 2005 May; 6(3):352-4. PubMed ID: 15857538
[TBL] [Abstract][Full Text] [Related]
19. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
[TBL] [Abstract][Full Text] [Related]
20. [Recombinant activated factor VII in the postanesthetic recovery unit: review of 16 cases].
Etxániz Alvarez A; Pita Zapata E; Rama Maceiras P; Duro Tacón J; Pose Cambeiro P
Rev Esp Anestesiol Reanim; 2006 Mar; 53(3):159-62. PubMed ID: 16671259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
